In This Article: CHICAGO (AP) — CHICAGO (AP) — Xeris Biopharma Holdings, Inc. (XERS) on Friday reported a loss of $15.7 million in its third quarter. On a per-share basis, the Chicago-based company said it had a loss of 11 cents. Losses, adjusted for non-recurring costs, came to 6 cents per…
Continue reading...
Continue reading...